Inactive Instrument

Ocata Therapeutics Inc Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

10/02/16	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
22/01/16	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
28/12/15	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
03/12/15	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
24/11/15	Ocata Therapeutics : Harwood Feffer LLP : Announces Investigation of Ocata Therapeutics, Inc.	PR

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	02/02/2015

Director	Title	Age	Since
Percival Barretto-Ko BRD	Director/Board Member	53	-
Masaaki Hirano BRD	Director/Board Member	59	-
Toru Yoshimitsu BRD	Director/Board Member	63	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-3.42%	+4.90%	+61.15%	+87.70%	55.98B
ARGENX SE	-0.56%	-2.33%	+52.00%	+70.48%	53.69B
INSMED INCORPORATED	-2.14%	-9.13%	+2.74%	+421.65%	23.29B
BIONTECH SE	-0.47%	-1.53%	-18.61%	-15.41%	23.15B
WUXI BIOLOGICS (CAYMAN) INC.	-5.85%	-2.42%	+30.88%	-9.33%	20.58B
GENMAB A/S	-1.97%	-2.05%	+34.41%	-27.98%	17.76B
PHARMAESSENTIA CORPORATION	-4.55%	-1.95%	+192.65%	+349.58%	16.09B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-6.45%	-5.17%	+27.42%	+649.50%	15.93B
EXELIXIS, INC.	+0.23%	-2.49%	+24.26%	+187.16%	14B
Average	-2.77%	-0.43%	+45.21%	+190.37%	26.72B
Weighted average by Cap.	-2.52%	-0.88%	+45.62%	+149.95%

Employees

Sector